GlobeNewswire Inc.··NaVaccinex Advances Alzheimer's Pipeline as Clinical-Stage Biotech Initiates Phase 2b Study
Vaccinex released 2025 financial results while launching Phase 2b Alzheimer's study, advancing its antibody therapy pipeline for neurodegenerative diseases and cancer.
VCNXfinancial resultsclinical-stage